8.2. Analysis.
Comparison 8: Non‐serious adverse events: cross‐over trials (endpoint data), Outcome 2: Subgroup analysis: total number of non‐serious adverse events according to dose
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.